This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Chembridge Corporation. Active years: 2011-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2014
Title: The Innovative Work of Inventor Zheng Yan
Introduction: Zheng Yan, a talented inventor based in San Diego, CA, has made significant contributions to the field of pharmaceuticals with his groundbreaking patents in tyrosine kinase inhibitors and heterocyclic compounds for the treatment of various diseases.
Latest Patents: Zheng Yan's latest patents include Tyrosine kinase inhibitors, which are compounds that modulate tyrosine kinase activity, and Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders, and immunomodulatory disorders. These inventions have the potential to revolutionize the pharmaceutical industry and improve the lives of countless individuals.
Career Highlights: Zheng Yan is currently employed at Chembridge Corporation, a renowned company in the field of drug discovery and development. His innovative research and dedication to advancing medical science have earned him a respected position within the industry.
Collaborations: Throughout his career, Zheng Yan has collaborated with esteemed colleagues such as Vlad Edward Gregor and Yahua Liu. Together, they have worked on cutting-edge projects that have paved the way for new advancements in drug therapies.
Conclusion: Zheng Yan's passion for innovation and his relentless pursuit of scientific excellence have solidified his reputation as a leading figure in the field of pharmaceutical research. His patents and collaborations are a testament to his commitment to improving global healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile